<DOC>
	<DOC>NCT01834807</DOC>
	<brief_summary>This retrospective, observational, multi-center study will evaluate the use of biological agents (e.g. RoActemra/Actemra [tocilizumab]) in monotherapy in patients with rheumatoid arthritis. Data from medical record files will be collected of patients currently treated with a biologic in monotherapy.</brief_summary>
	<brief_title>A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Adult patients, &gt;/= 18 years of age Diagnosis of rheumatoid arthritis Currently receiving a biologic agent in monotherapy (corticosteroids and/or nonsteroidal antiinflammatory drugs are permitted) Concomitant treatment with diseasemodifying antirheumatic drugs (DMARDs) for the treatment of rheumatoid arthritis Patients that have started their current monotherapy before 01/01/2009</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>